Abstract-The effects of narcotic analgesics on the brain 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels of rats and mice were investigated in relation to our preceding data on the effect of humoral modulators on morphine induced changes in locomotor activity and body temperature of rodents. The results suggest that morphine accelerates the release of brain 5-HT both in rats and mice, and that neither methadone nor pethidine alters the brain 5-HT and 5-HIAA levels in rats. The morphine-induced increase in brain 5-HT turnover is likely to be involved in the morphine-induced decrease in locomotor activity and hypothermia in rats. The activity-decreasing effects of methadone or pethidine, on the other hand, are mediated by mechanisms different from those which mediate the effects of morphine.
There have been numerous reports which suggest the participation of 5-hydroxy tryptamine (5-HT, serotonin), a putative neurotransmitter in the brain, in some of the pharmacological effects of narcotic analgesics. There are numerous conflicting reports however, on the relation among narcotics, their pharmacological effects, and serotonin.
For example, the acute administration of morphine is reported either to produce an increase in cerebral 5-HT turnover in mice (1) and in rats (2, 3), or not to alter the serotonin turnover in mouse brain (4) (5) (6) . p-Chlorophenylalanine (p-CPA), a serotonin depletor, is shown either to augment the levorphanol-induced running activity in mice (7) , to be ineffective on morphine-stimulated locomotor activity of mice (8) and on levorphanol-induced running activity in mice (9) , to reduce the morphine-induced hyperactivity in mice (10) , or to reverse the morphine-induced hypoactivity to hyperactivity in rats (6, (11) (12) (13) . These discrepancies may not be due to species differences only but also to differences in animal suppliers since it is well known that analgesic doses of morphine produce hyperactivity in mice but hypo activity in rats, the morphine-induced change in cerebral 5-HT turnover is prominently different among mice obtained from different suppliers (14) , and morphine-induced changes in body temperature of Wistar rats from the same supplier (hyperthermia) are opposite to those of Wistar rats from another supplier (hypothermia) (15) . In an attempt at clarification, we studied the effect of narcotic analgesics on the cerebral 5-HT in rodents as the effect of p-CPA on the morphine-induced changes in locomotor activity and in body temperature has already been reported in these animals (13, (16) (17) (18) (19) . All drugs were administered in volumes of 5 ml/kg and all dosages were expressed in terms of their salts. Data were statistically analyzed using Student's t-test.
RESULTS
Brain 5-HIAA concentration in rats was significantly increased one hr after admin istration of 2.5, 5, 10 or 20 mg/kg of morphine-HC1. This concentration was unchanged, however, with 1.25 mg/kg of morphine. Thus, the morphine-induced increase in 5-HIAA level appears to be a dose-related phenomenon.
In contrast, 5-HT level of the rat brain was not altered significantly with a wide range of doses (Table 1) . Either saline (5 ml/kg) or morphine (20 mg/kg) was administered s.c. twice daily (9 a.m. and 5 p.m.) for fifteen days and rats were sacrificed one hr after the last injection. Pretreatment of rats with naloxone, a specific narcotic antagonist, prevented the mor phine-induced elevation of 5-HIAA concentration, to which tolerance developed by the repeated administration of morphine (Tables 2 and 3 (Table 4 ). Values of the group on saline are those in Table 1 , but have been included here for ease of comparison. Saline, methadone or pethidine was injected s.c. one hr before decapitation. Atropine, a muscarinic antagonist, did not alter the morphine-induced increase in the brain 5-HIAA level (Table 5) .
Methadone or pethidine, narcotic analgesics like morphine, had little effect on the 5-HT and 5-HIAA levels of rat brain ( Table 6 ).
The morphine-induced increase in 5-HIAA level was observed not only in the rat but also in the mouse brain and the augmentation was prevented by naloxone (Tables 7 and 8 ).
On the other hand, the 5-HT level in the mouse brain was not affected by morphine.
DISCUSSION
The data in the present investigation suggest that an increase in the turnover of brain 5-HT may be caused by the acute administration of morphine to rodents, but this increase did not occur with methadone or pethidine.
An increase in the cerebral 5-HT turnover is suggested by the fact that the acute admin istration of morphine to rats causes an increase in the brain 5-HIAA level. Moreover, morphine augments an increase in brain 5-HIAA concentration induced by the adminis tration of 200 mg/kg of probenecid, a supramaxmal dose for the blockade of the acid trans port system in rat brain (21) . Additionally, the decline of 5-HIAA level after MAO in hibition by pargyline is not affected by morphine. Thus, the morphine-induced increase in the brain 5-HIAA concentration is not due to the blockade of the cerebral acid transport system but rather to the enhancement of turnover of 5-HT. The increase in brain 5-HT turnover by morphine, however, is assumed to be caused by a feedback mechanism due to the enhanced release of 5-HT since brain 5-HT turnover has been shown to increase when 5-HT levels are reduced by reserpine treatment (22) and when brain 5-HT levels are in creased by pargyline, morphine has no additional increasing-effect on this elevated level of 5-HT by MAO inhibitor (Table 4) . Finally, no alteration was observed in the in vitro activity of tryptophan hydroxylase, an enzyme which catalyzes the rate-limiting step in 5-HT biosynthesis, after a single injection of morphine (3) and the morphine-induced respiratory depression may result in a decrease in molecular oxygen, one of the substrates for tryptophan hydroxylase (23) .
Morphine may have no effect on the residual 5-HT after p-CPA administration since this narcotic did not affect the 5-HT and 5-HIAA levels after p-CPA injection (Table 4 ).
The purpose of the present investigation was to determine whether or not brain 5-HT is involved in some of the pharmacological effects of narcotic analgesics on rodents. p-CPA, a serotonin depletor, has been shown to inhibit the morphine-induced decrease in locomotor activity of rats (11) (12) (13) and the morphine-induced hypothermia of rats (17, 18) . Thus, the release of central 5-HT by morphine appears to be involved in the appearance of these depressant actions of morphine on rats. Moreover, supportable evidence for the involve ment of 5-HT is that both an increase in the brain 5-HIAA level and these depressant effects by morphine are antagonized by naloxone and tolerance is developed to both phenomena.
Previous results showed that antimuscarinic drugs had significant effects on the mor phine-induced changes in locomotor activity (13) and in body temperature of rats (18) . Thus, it was of interest to determine the effect of cholinergic antagonists on the brain 5-HT.
Data in the present investigation, however, indicate that atropine has almost no effect on brain 5-HT in rats. Thus, antimuscarinic drugs appear to affect the morphine-induced changes directly or through a mechanism other than the serotonergic one.
Pethidine or methadone may also produce a decrease in locomotor activity of rats by the serotonergic mechanism since pretreatment of rats with p-CPA significantly inhibited these narcotic-induced decreases in locomotor activity (24) . The fact that methadone or pethidine does not alter the 5-HT and 5-HIAA levels in the rat brain, however, suggests that the activity-decreasing effects of methadone or pethidine are mediated by mechanisms different from those which mediate the effects of morphine. Both methadone and pethidine have been shown to inhibit the uptake mechanism of serotonergic neurons (25, 26) . The inhibition of the 5-HT uptake appears to be involved in the activity-decreasing effects of methadone or pethidine.
In contrast, although morphine increases the brain 5-HIAA level in mice, cerebral 5-HT does not appear to play an important role in the morphine-stimulated running activity of mice since p-CPA has been shown to have no effect on this stimulatory effect (16) . Putative neurotransmitters other than 5-HT such as catecholamines or acetylcholine may indeed be involved in the morphine-induced increase in locomotor activity as already suggested by Rethy et al. (27) , and Oka and Hosoya (16) . The morphine-induced increase in the brain 5-HIAA level in mice may be related to pharmacological effects other than the activity increasing effect of morphine.
